The instinct to protect and secure a child’s future—especially when it comes to their health—is one of the deepest and most ...

New report adds to growing evidence of iNKT cell therapy’s potential in solid tumorsNEW YORK, July 11, 2025 (GLOBE NEWSWIRE) ...

Research led by Naval Medical University's Changzheng Hospital in China reports that an off-the-shelf cell therapy built from ...

MiNK Therapeutics shares jumped as new clinical data show durable remission in testicular cancer and tumor reduction in ...

MiNK Therapeutics surged on tumor remission data for agenT-797, but financial risks and limited clinical proof remain. Learn ...

Even a little movement goes a long way. As Dr. George explains, just 75 minutes of activity a week, that’s about 11 minutes a ...

Your immune system needs sunlight like plants need water. Without adequate exposure to natural light, your body's defense mechanisms weaken in ways most ...

AnaptysBio’s lead drug rosnilimab showed promise in RA, but lack of a Phase 3 plan and limited pipeline raise concerns. Find ...

NetworkNewsWire Editorial Coverage NEW YORK, July 9, 2025 /PRNewswire/ -- Each year, approximately 20 million people are ...

In an interview with Moneycontrol on July 14, Glenn Saldanha, Chairman and Managing Director of Glenmark, discussed the ...

By Bunmi Sofola Recently scientific research has shown the risk of having heart failure or a stroke doubles in the first ...

Calidi Biotherapeutics Inc. has spent over 10 years developing a groundbreaking platform for the systemic delivery of genetic medicines that can precisely target tumors. One of the company's core ...